Global health surveillance from the WHO and CDC shows no novel pathogen with sustained human-to-human transmission capable of sparking a pandemic in 2026, supporting the market's 88.5% implied probability for no new event. Current outbreaks, including Bundibugyo Ebola in the Democratic Republic of the Congo and Uganda plus limited Hantavirus cases, remain geographically contained with low transmission risk according to official assessments. COVID-19 infections continue declining across most U.S. states with reproductive numbers near or below 1, while routine monitoring detects only familiar threats like seasonal influenza variants or localized salmonella clusters. Post-2020 enhancements in genomic sequencing, wastewater tracking, and international reporting have improved early detection, reducing the likelihood of undetected spread. Historical zoonotic spillover models estimate annual pandemic-scale risk at roughly 2.5–3.3%, consistent with trader consensus absent major shifts in emerging pathogen data.